T

TargED Biopharmaceuticals

20 employees

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Microvascular thrombosis
Health Care
Pharmaceutical
Biopharma
Thrombolysis
Biologicals

Date founded

2018

Funding rounds raised

Total raised

$44M

from 9 investors over 9 rounds

T

TargED Biopharmaceuticals raised $44M on February 19, 2022

Investors: Utrecht Holdings (Universiteit Utrecht), Andera Partners, Inkef, Sunstone Life Science Ventures, FundPlus, Hadean Ventures and Curie Capital BV

T

TargED Biopharmaceuticals raised $1.7M on November 24, 2020

Investors: Utrecht Holdings (Universiteit Utrecht) and Curie Capital BV

FAQ